Filing Details
- Accession Number:
- 0001062993-23-007483
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-22 16:05:01
- Reporting Period:
- 2023-03-20
- Accepted Time:
- 2023-03-22 16:05:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
10456 | Baxter International Inc | BAX | Surgical & Medical Instruments & Apparatus (3841) | 360781620 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1205438 | L P Albert Stroucken | One Baxter Parkway Deerfield IL 60015 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $1 Par Value | Acquisiton | 2023-03-20 | 3,930 | $36.93 | 40,765 | No | 4 | M | Direct | |
Common Stock, $1 Par Value | Disposition | 2023-03-20 | 3,930 | $37.52 | 36,835 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock, $1 Par Value | Stock Option (Right to Buy) | Disposition | 2023-03-20 | 3,930 | $0.00 | 3,930 | $36.93 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2014-05-07 | 2023-05-05 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock, $1 Par Value | 696 | Indirect | By Family Trust |
Footnotes
- Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Mr. Stroucken on February 16, 2023 with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Stroucken which were scheduled to expire on May 5, 2023.